Journals / Journal of Clinical and Analytical Medicine / 2014 / Cilt: 5 - Sayı: 6

Diyabetik Retinopati ile Sistemik Faktörler Arasındaki ilişki

The Relationship Between Diabetic Retinopathy and Systemic Factors

Pages
530–536
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, systemicrisk factors of diabetic retinopathy were discussed with the review of recentliterature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Diabetes mellitus is a disease that affects entire the world and its prevalence is increasing.
📊
Key Findings & Data:Most patients with diabetes mellitus will have developeddiabetic retinopathy which can cause blindness in time.
💡
Conclusion & Impact:In this study, systemicrisk factors of diabetic retinopathy were discussed with the review of recentliterature.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Diabetes mellitus is a disease that affects entire the world and its prevalence is increasing. Most patients with diabetes mellitus will have developeddiabetic retinopathy which can cause blindness in time. The treatment ofretinopathy, a microvascular complication of diabetes mellitus, needs a multifaceted approach. For the follow up of diabetic retinopathy, beside ophthalmologist and endocrinologist, family physician and dietician as well shouldbe aware of the disease. Delaying the formation of diabetic retinopathy orto have low intensity can be controlled by systemic factors. In patients withpoor regulation of blood sugar, blood pressure and blood lipid profil, retinopathy is seen earlier and its progress is increasing. Therefore, regulationof systemic factors associated with the formation of diabetic retinopathy isvery important in the fight against this complication. In this study, systemicrisk factors of diabetic retinopathy were discussed with the review of recentliterature.

Özet

Diyabetes mellitus tüm dünyayı etkileyen ve giderek prevelansı artan bir hastalıktır. Hastaların neredeyse tamamında zaman içinde körlüğe neden olabilen diyabetik retinopati görülür. Hastalığın mikrovasküler komplikasyonu olandiyabetik retinopati tedavisi çoklu yaklaşım gerektirmektedir. Göz ve endokrin doktoru yanında aile hekimi ve diyetisyen gibi diyabet hastası takibi yapanuzmanların da bu konuda bilinçli olması gereklidir. Retinopati oluşumunun geciktirilmesi ya da düşük şiddetli olması sistemik faktörler tarafından kontroledilebilmektedir. Kan şeker regülasyonu kötü olan, kan basıncı yüksek olan velipid profili kötü olan hastalarda retinopati daha erken ortaya çıkmakta ve retinopati progresyonu artmaktadır. Bu nedenle retinopati oluşumu ile ilişkilisistemik faktörlerin regülasyonu bu komplikasyon ile mücadelede çok önemlidir. Bu derlemede, güncel literatür bilgileri ışığında sistemik risk faktörlerinindiyabetik retinopati üzerine etkileri gözden geçirilmiştir.

🔖

Cite This Article

ALİM, S., DEMİR, A. K. (2022). Diyabetik Retinopati ile Sistemik Faktörler Arasındaki ilişki. Journal of Clinical and Analytical Medicine, Cilt: 5 - Sayı: 6, 530–536. https://ajindex.com/articles/561205

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev 2013;93(1):137-88
  2. Bihan H, Ramentol M, Fysekidis M, Auclair C, Gerbaud L, Desbiez F, et al. Scre- ening for deprivation using the EPICES score: a tool for detecting patients at high risk of diabetic complications and poor quality of life. Diabetes Metab 2012;38(1):82-5
  3. Mohamed Q, Gillies MC, Wong TY. retinopathy: a systematic review. JAMA 2007;298(8):902-16
  4. Hiller R, Sperduto RD, Podgor MJ, Ferris FL, 3rd, Wilson PW. Diabetic retinopathy and cardiovascular disease in type II diabetics. The Framingham Heart Study and the Framingham Eye Study. Am J Epidemiol 1988;128(2):402-9
  5. Wong TY, Cheung N, Islam FM, Klein R, Criqui MH, Cotch MF, et al. Relation of retinopathy to coronary artery calcification: the multi-ethnic study of atherosclerosis. Am J Epidemiol 2008;167(1):51-8
  6. Cheung N, Wong TY. Diabetic retinopathy and systemic vascular complications. Prog Retin Eye Res 2008;27(2):161-76
  7. Klein R, Klein BE, Moss SE, Cruickshanks KJ. Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol 1999;117(11):1487-95
  8. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiolo- gic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102(4):520-6
  9. Klein R, Sharrett AR, Klein BE, Moss SE, Folsom AR, Wong TY, et al. The as- sociation of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes: the atherosclerosis risk in communities study. Ophthalmology 2002;109(7):1225-34
  10. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Dia- betologia 1989;32(4):219-26
  11. Parving HH, Nielsen FS, Bang LE, Smidt UM, Svendsen TL, Chen JW, et al. Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy. Diabetologia 1996;39(12):1590-7
  12. Gratton I, Gazocchi M, Simonini F, Fattori CM, Citroni M. Argon laser photoco- agulation in the management of retinal detachment and predisposing lesions. La- sers Surg Med 1984;4(4):337-44
  13. Aylward GW, Pearson RV, Jagger JD, Hamilton AM. Extensive argon laser pho- tocoagulation in the treatment of proliferative diabetic retinopathy. Br J Ophthalmol 1989;73(3):197-201
  14. Salman AG. Intrasilicone bevacizumab injection for iris neovascularizat